Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BIIB:US

396.990 USD 3.110 0.78%

As of 17:20:00 ET on 05/29/2015.

Company Profile for Biogen Inc (BIIB)

Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

Contact Information

Biogen Inc

225 Binney Street
Cambridge, MA 02142
United States
Phone: 781-464-2000

Key Executives for Biogen Inc (BIIB)

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOStephen H Holtzman "Steve"Exec VP:Corporate Development
Stuart A Kingsley "Tony"Exec VP:Global Commercial OpsKenneth Di PietroExec VP:Human Resources
John G CoxExec VP:PharmaceuticalDouglas Edward Williams "Doug"Exec VP:Research & Dev
Adriana Karaboutis "Andi"Exec VP:Tech & Bus SolutionsMatt GriffithsSenior VP/Chief Information Ofcr
Alfred W Sandrock JrSenior VP/Chief Medical OfcrAdam M KoppelSenior VP/Chief Strategy Ofcr
Spyros Artavanis-TsakonasSenior VP/Chief Scientific OfcrGregory F CovinoVP:Finance/Chief Acctg Ofcr
Karen JewellInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil